BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23459046)

  • 41. Identification of clinical and laboratory markers for predicting eosinophilic esophagitis in adults.
    von Arnim U; Wex T; Röhl FW; Neumann H; Küster D; Weigt J; Mönkemüller K; Malfertheiner P
    Digestion; 2011; 84(4):323-7. PubMed ID: 22075653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric Eosinophilic Esophagitis.
    Posten S; Adamiak T; Jensen M
    S D Med; 2018 Aug; 71(8):362-366. PubMed ID: 30110527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of proton pump inhibitor on esophageal eosinophilia.
    Schroeder S; Capocelli KE; Masterson JC; Harris R; Protheroe C; Lee JJ; Furuta GT
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):166-72. PubMed ID: 23325438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
    Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
    J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs.
    Warners MJ; van Rhijn BD; Curvers WL; Smout AJ; Bredenoord AJ
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):506-11. PubMed ID: 25822858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature.
    Molina-Infante J; Ferrando-Lamana L; Mateos-Rodríguez JM; Pérez-Gallardo B; Prieto-Bermejo AB
    World J Gastroenterol; 2008 Mar; 14(9):1463-6. PubMed ID: 18322968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Evolving Approach to the Diagnosis of Eosinophilic Esophagitis.
    Kim HP; Dellon ES
    Gastroenterol Hepatol (N Y); 2018 Jun; 14(6):358-366. PubMed ID: 30166949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: A cross-sectional study from a tertiary care hospital in North India.
    Baruah B; Kumar T; Das P; Thakur B; Sreenivas V; Ahuja V; Gupta SD; Makharia GK
    Indian J Gastroenterol; 2017 Sep; 36(5):353-360. PubMed ID: 29022245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia.
    Podboy A; Katzka DA; Enders F; Larson JJ; Geno D; Kryzer L; Alexander J
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1168-77. PubMed ID: 27028344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
    Safroneeva E; Saner C; Rossel JB; Golay D; Pittet V; Godat S; Diem S; Aepli P; Sawatzki M; Borovicka J; Burgmann K; Juillerat P; Netzer P; Sendensky A; Hruz P; Girardin M; Biedermann L; Greuter T; Vavricka S; Michetti P; Mueller C; Straumann A; Schoepfer AM;
    Inflamm Intest Dis; 2018 Mar; 2(3):163-170. PubMed ID: 30018966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.
    Abu-Sultaneh SM; Durst P; Maynard V; Elitsur Y
    Dig Dis Sci; 2011 Jan; 56(1):97-102. PubMed ID: 20458625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
    Dellon ES; Liacouras CA; Molina-Infante J; Furuta GT; Spergel JM; Zevit N; Spechler SJ; Attwood SE; Straumann A; Aceves SS; Alexander JA; Atkins D; Arva NC; Blanchard C; Bonis PA; Book WM; Capocelli KE; Chehade M; Cheng E; Collins MH; Davis CM; Dias JA; Di Lorenzo C; Dohil R; Dupont C; Falk GW; Ferreira CT; Fox A; Gonsalves NP; Gupta SK; Katzka DA; Kinoshita Y; Menard-Katcher C; Kodroff E; Metz DC; Miehlke S; Muir AB; Mukkada VA; Murch S; Nurko S; Ohtsuka Y; Orel R; Papadopoulou A; Peterson KA; Philpott H; Putnam PE; Richter JE; Rosen R; Rothenberg ME; Schoepfer A; Scott MM; Shah N; Sheikh J; Souza RF; Strobel MJ; Talley NJ; Vaezi MF; Vandenplas Y; Vieira MC; Walker MM; Wechsler JB; Wershil BK; Wen T; Yang GY; Hirano I; Bredenoord AJ
    Gastroenterology; 2018 Oct; 155(4):1022-1033.e10. PubMed ID: 30009819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baseline Peripheral Eosinophil Count Independently Predicts Proton Pump Inhibitor Response in Eosinophilic Esophagitis.
    Muftah M; Barshop K; Redd WD; Goldin AH; Lo WK; Chan WW
    J Clin Gastroenterol; 2024 Mar; 58(3):242-246. PubMed ID: 36943488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required.
    Lipka S; Muhammad A; Champeaux A; Richter JE
    Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in clinical management of eosinophilic esophagitis.
    Dellon ES; Liacouras CA
    Gastroenterology; 2014 Dec; 147(6):1238-54. PubMed ID: 25109885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two cases of esophageal eosinophilia: eosinophilic esophagitis or gastro-esophageal reflux disease?
    Yilmaz O; Karagol HI; Topal E; Unlusoy AA; Egritas O; Gonul II; Bakirtas A
    Pediatr Rep; 2014 May; 6(2):5160. PubMed ID: 24987510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
    Hait EJ; McDonald DR
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):213-225. PubMed ID: 30206783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eosinophilic esophagitis: a practical approach to diagnosis and management.
    Molina-Infante J; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):925-34. PubMed ID: 24830679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.
    Kochar B; Dellon ES
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1359-69. PubMed ID: 26365201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice.
    Cheng E
    Curr Treat Options Gastroenterol; 2015 Mar; 13(1):30-46. PubMed ID: 25598233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.